BOSTON--(BUSINESS WIRE)--pSivida Corp, (NASDAQ:PSDV)(ASX:PSD)(FF:PSI), a leading drug delivery company, today announced that Dr. Paul Ashton, President and Chief Executive Officer, will make a presentation on ocular drug delivery systems at the fifth annual IBC International Conference on Ocular Angiogenesis and Retinal Degeneration, to be held in Las Vegas, March 30 and 31. The Conference provides state-of-the-art research information on therapeutic development for ocular disease including research targeting unmet needs and therapeutic advances that improve available treatment options.
